FDA Seeks PMA Requirements For More Pre-Amendment Devices
This article was originally published in The Gray Sheet
FDA is proposing to require pre-market approval applications for three class III, pre-amendment device types in the cardiovascular and neurologic device spaces.
You may also be interested in...
Dueling Journal Commentaries Revisit FDA Approval of Abiomed's Impella
The pieces in JAMA Cardiology consider the merits of FDA's "515 Program Initiative" to classify preamendment devices and its application to a minimally invasive ventricular assist device.
Class Act: Status Of CDRH’s 515 Initiative
Chart updating FDA’s progress and decisions in classifying the final set of preamendment devices.
Regulatory News In Brief
President Obama signs FDA user fee bill. FDA issues rules requiring PMAs for two pre-amendment devices. More regulatory news.